Modification of small ubiquitin-related modifier 2 (SUMO2) by phosphoubiquitin in HEK293T cells.

HEK293T, phosphorylation, post-translational modification, Ser65 SUMO2, ubiquitin, unanchored polyubiquitin

Journal

Proteomics
ISSN: 1615-9861
Titre abrégé: Proteomics
Pays: Germany
ID NLM: 101092707

Informations de publication

Date de publication:
08 2021
Historique:
revised: 21 05 2021
received: 05 09 2020
accepted: 25 05 2021
pubmed: 5 6 2021
medline: 26 10 2021
entrez: 4 6 2021
Statut: ppublish

Résumé

Additional complexity in the post-translational modification of proteins by ubiquitin is achieved by ubiquitin phosphorylation, for example within PINK1-parkin mediated mitophagy. We performed a preliminary proteomic analysis to identify proteins differentially modified by ubiquitin in HEK293T, compared to phosphomimetic ubiquitin (Ser65Asp), and identified small ubiquitin-related modifier 2 (SUMO2) as a candidate. By transfecting SUMO2 and its C-terminal-GG deletion mutant, along with phosphomimetic ubiquitin, we confirm that ubiquitin modifies SUMO2, rather than vice versa. Further investigations revealed that transfected SUMO2 can also be conjugated by endogenous phospho-Ser65-(poly)ubiquitin in HEK293T cells, pointing to a previously unappreciated level of complexity in SUMO2 modification, and that unanchored (substrate-free) polyubiquitin chains may also be subject to phosphorylation.

Identifiants

pubmed: 34086420
doi: 10.1002/pmic.202000234
doi:

Substances chimiques

SUMO2 protein, human 0
Small Ubiquitin-Related Modifier Proteins 0
Ubiquitin 0
Polyubiquitin 120904-94-1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2000234

Informations de copyright

© 2021 The Authors. Proteomics published by Wiley-VCH GmbH.

Références

Goldstein, G., Scheid, M., Hammerling, U., Schlesinger, D. H., Niall, H. D., & Boyse, E. A. (1975). Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proceedings of the National Academy of Sciences of the United States of America, 72(1), 11-15.
Vijay-Kumar, S., Bugg, C. E., Wilkinson, K. D., & Cook, W. J. (1985). Three-dimensional structure of ubiquitin at 2.8 A resolution. Proceedings of the National Academy of Sciences of the United States of America, 82(11), 3582-3585.
Hershko, A., Ciechanover, A., Heller, H., Haas, A. L., & Rose, I. A. (1980). Proposed role of ATP in protein breakdown: Conjugation of protein with multiple chains of the polypeptide of ATP-dependent proteolysis. Proceedings of the National Academy of Sciences of the United States of America, 77(4), 1783-1786.
Swatek, K. N., & Komander, D. (2016). Ubiquitin modifications. Cell Research, 26(4), 399-422.
Thrower, J. S., Hoffman, L., Rechsteiner, M., & Pickart, C. M. (2000). Recognition of the polyubiquitin proteolytic signal. European Molecular Biology Organization Journal, 19(1), 94-102.
Tan, J. M. M., Wong, E. S. P., Kirkpatrick, D. S., Pletnikova, O., Ko, H. S., Tay, S.-.P., Ho, M. W. L., Troncoso, J., Gygi, S. P., Lee, M. K., Dawson, V. L., Dawson, T. M., & Lim, K. -. L. (2008). Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Human Molecular Genetics, 17(3), 431-439.
Olzmann, J. A., & Chin, L. -. S. (2008). Parkin-mediated K63-linked polyubiquitination: A signal for targeting misfolded proteins to the aggresome-autophagy pathway. Autophagy, 4(1), 85-87.
Xia, Z.-.P., Sun, L., Chen, X., Pineda, G., Jiang, X., Adhikari, A., Zeng, W., & Chen, Z. J. (2009). Direct activation of protein kinases by unanchored polyubiquitin chains. Nature, 461(7260), 114-119. https://doi.org/10.1038/nature08247.[CrossRef]
Qi, J., & Ronai, Z. A. (2015). Dysregulation of ubiquitin ligases in cancer. Drug Resistance Updates, 23, 1-11.
Zheng, Q., Huang, T., Zhang, L., Zhou, Y., Luo, H., Xu, H., & Wang, X. (2016). Dysregulation of ubiquitin-proteasome system in neurodegenerative diseases. Frontiers in Aging Neuroscience, 8, 303. https://doi.org/10.3389/fnagi.2016.00303.[CrossRef]
Willis, M. S., Bevilacqua, A., Pulinilkunnil, T., Kienesberger, P., Tannu, M., & Patterson, C. (2014). The role of ubiquitin ligases in cardiac disease. Journal of Molecular and Cellular Cardiology, 71, 43-53.
Song, S., Jang, S., Park, J., Bang, S., Choi, S., Kwon, K. -. Y., Zhuang, X., Kim, E., & Chung, J. (2013). Characterization of PINK1 (PTEN-induced putative kinase 1) mutations associated with parkinson disease in mammalian cells and drosophila. Journal of Biological Chemistry, 288(8), 5660-5672.
Kane, L. A., Lazarou, M., Fogel, A. I., Li, Y., Yamano, K., Sarraf, S. A., Banerjee, S., & Youle, R. J. (2014). PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. Journal of Cell Biology, 205(2), 143-153.
Kazlauskaite, A., Kondapalli, C., Gourlay, R., Campbell, D. G., Ritorto, M. S., Hofmann, K., Alessi, D. R., Knebel, A., Trost, M., & Muqit, M. M. K. (2014). Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65. Biochemical Journal, 460(1), 127-141.
Koyano, F., Okatsu, K., Kosako, H., Tamura, Y., Go, E., Kimura, M., Kimura, Y., Tsuchiya, H., Yoshihara, H., Hirokawa, T., Endo, T., Fon, E. A., Trempe, J. -. F., Saeki, Y., Tanaka, K., & Matsuda, N. (2014). Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature, 510(7503), 162-166.
Fiesel, F. C., Ando, M., Hudec, R., Hill, A. R., Castanedes-Casey, M., Caulfield, T. R., Moussaud-Lamodière, E. L., Stankowski, J. N., Bauer, P. O., Lorenzo-Betancor, O., Ferrer, I., Arbelo, J. M., Siuda, J., Chen, Li, Dawson, V. L., Dawson, T. M., Wszolek, Z. K., Ross, O. A., Dickson, D. W., & Springer, W. (2015). (Patho-)physiological relevance of PINK1-dependent ubiquitin phosphorylation. European Molecular Biology Organization Reports, 16(9), 1114-1130.[CrossRef]
Ordureau, A., Sarraf, S. A., Duda, D. M., Heo, J -Mi, Jedrychowski, M. P., Sviderskiy, V. O., Olszewski, J. L., Koerber, J. T., Xie, T., Beausoleil, S. A., Wells, J. A., Gygi, S. P., Schulman, B. A., & Harper, J. W, (2014). Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis. Molecular Cell, 56(3), 360-375.
Wauer, T., Swatek, K. N., Wagstaff, J. L., Gladkova, C., Pruneda, J. N., Michel, M. A., Gersch, M., Johnson, C. M., Freund, S. Mv., & Komander, D. (2015). Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis. European Molecular Biology Organization Journal, 34(3), 307-325.[CrossRef]
Okatsu, K., Koyano, F., Kimura, M., Kosako, H., Saeki, Y., Tanaka, K., & Matsuda, N. (2015). Phosphorylated ubiquitin chain is the genuine Parkin receptor. Journal of Cell Biology, 209(1), 111-128.
Dong, Xu, Gong, Z., Lu, Y. -. Bi., Liu, K., Qin, L. -. Y., Ran, M. -. L., Zhang, C. -. Li., Liu, Z., Zhang, W. -. P., & Tang, C. (2017). Ubiquitin S65 phosphorylation engenders a pH-sensitive conformational switch. Proceedings of the National Academy of Sciences of the United States of America, 114(26), 6770-6775.
Huguenin-Dezot, N., De Cesare, V., Peltier, J., Knebel, A., Kristaryianto, Y. A., Rogerson, D. T., Kulathu, Y., Trost, M., & Chin, J. W. (2016). Synthesis of Isomeric Phosphoubiquitin chains reveals that phosphorylation controls deubiquitinase activity and specificity. Cell reports, 16(4), 1180-1193.
Mcwilliams, T. G., Barini, E., Pohjolan-Pirhonen, R., Brooks, S. P., Singh, F., Burel, S., Balk, K., Kumar, A., Montava-Garriga, L., Prescott, A. R., Hassoun, S. M., Mouton-Liger, F., Ball, G., Hills, R., Knebel, A., Ulusoy, A., Di Monte, D. A., Tamjar, J., Antico, O., … Muqit, M. M. K. (2018). Phosphorylation of Parkin at serine 65 is essential for its activation in vivo. Open Biology, 8(11), 180108.
Swaney, D. L., Rodríguez-Mias, R. A., & Villén, J. (2015). Phosphorylation of ubiquitin at Ser65 affects its polymerization, targets, and proteome-wide turnover. European Molecular Biology Organization Reports, 16(9), 1131-1144.[CrossRef]
Yamano, K., Queliconi, B. B., Koyano, F., Saeki, Y., Hirokawa, T., Tanaka, K., & Matsuda, N. (2015). Site-specific interaction mapping of phosphorylated ubiquitin to uncover parkin activation. Journal of Biological Chemistry, 290(42), 25199-25211.
Strachan, J., Shaw, B., Krishna, V. G., Scott, D., del Pozo, J. C., Hill, K., … Layfield, R. (2013). Broad utility of an affinity-enrichment strategy for unanchored polyubiquitin chains. Journal of Proteomics & Bioinformatics, S7(001). http://doi.org/10.4172/jpb.S7-001.
Scott, D., Strachan, J., Krishna, V. G., Shaw, B., Tooth, D. J., Searle, M. S., Oldham, N. J., & Layfield, R. (2016). Method for the purification of endogenous unanchored polyubiquitin chains. Methods in Molecular Biology, 1449, 203-213.
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. Proceedings of the National Academy of Sciences of the United States of America, 92(16), 7297-7301.
Demeneix, B., Behr, J., Boussif, O., Zanta, M. A., Abdallah, B., & Remy, J. (1998). Gene transfer with lipospermines and polyethylenimines. Advanced Drug Delivery Reviews, 30(1-3), 85-95.
Ducker, C., Chow, L. K. Y., Saxton, J., Handwerger, J., Mcgregor, A., Strahl, T., Layfield, R., & Shaw, P. E. (2019). De-ubiquitination of ELK-1 by USP17 potentiates mitogenic gene expression and cell proliferation. Nucleic Acids Research, 47(9), 4495-4508.
Scott, D., Garner, T. P., Long, J., Strachan, Jo, Mistry, S. C., Bottrill, A. R., Tooth, D. J., Searle, M. S., Oldham, N. J., & Layfield, R. (2016). Mass spectrometry insights into a tandem ubiquitin-binding domain hybrid engineered for the selective recognition of unanchored polyubiquitin. Proteomics, 16(14), 1961-1969. https://doi.org/10.1002/pmic.201600067.
Thomas, B., Mcintosh, D., Fildes, T., Smith, L., Hargrave, F., Islam, M., Thompson, T., Layfield, R., Scott, D., Shaw, B., Burrell, C. L., Gonzalez, S., & Taylor, S. (2017). Second-harmonic generation imaging of collagen in ancient bone. Bone Reports, 7, 137-144.
Danielsen, J. M. R., Sylvestersen, K. B., Bekker-Jensen, S., Szklarczyk, D., Poulsen, J. W., Horn, H., Jensen, L. J., Mailand, N., & Nielsen, M. L. (2011). Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. Molecular and Cellular Proteomics, 10(3), M110 003590.
Matic, I., Van Hagen, M., Schimmel, J., Macek, B., Ogg, S. C., Tatham, M. H., Hay, R. T., Lamond, A. I., Mann, M., & Vertegaal, A. C. O.. (2008). In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Molecular and Cellular Proteomics, 7(1), 132-144.
Barodia, S. K., Mcmeekin, L. J., Creed, R. B., Quinones, E. K., Cowell, R. M., & Goldberg, M. S. (2019). PINK1 phosphorylates ubiquitin predominantly in astrocytes. NPJ Parkinson's disease, 5, 29. https://doi.org/10.1038/s41531-019-0101-9.[CrossRef]
Amerik, A., Swaminathan, S., Krantz, B. A., Wilkinson, K. D., & Hochstrasser, M. (1997). In vivo disassembly of free polyubiquitin chains by yeast Ubp14 modulates rates of protein degradation by the proteasome. European Molecular Biology Organization Journal, 16(16), 4826-4838.
Braten, O., Shabek, N., Kravtsova-Ivantsiv, Y., & Ciechanover, A. (2012). Generation of free ubiquitin chains is up-regulated in stress and facilitated by the HECT domain ubiquitin ligases UFD4 and HUL5. Biochemical Journal, 444(3), 611-617.
Ouyang, H., Ali, Y. O., Ravichandran, M., Dong, A., Qiu, W., Mackenzie, F., Dhe-Paganon, S., Arrowsmith, C. H., & Zhai, R. G, (2012). Protein aggregates are recruited to aggresome by histone deacetylase 6 via unanchored ubiquitin C termini. Journal of Biological Chemistry, 287(4), 2317-2327.
Pertel, T., Hausmann, S., Morger, D., Züger, S., Guerra, J., Lascano, J., Reinhard, C., Santoni, F. A., Uchil, P. D., Chatel, L., Bisiaux, A., Albert, M. L., Strambio-De-Castillia, C., Mothes, W., Pizzato, M., Grütter, M. G., & Luban, J. (2011). TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature, 472(7343), 361-365.
Piotrowski, J., Beal, R., Hoffman, L., Wilkinson, K. D., Cohen, R. E., & Pickart, C. M. (1997). Inhibition of the 26 S proteasome by polyubiquitin chains synthesized to have defined lengths. Journal of Biological Chemistry, 272(38), 23712-23721.
Zeng, W., Sun, L., Jiang, X., Chen, X., Hou, F., Adhikari, A., Xu, M., & Chen, Z. J. (2010). Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell, 141(2), 315-330.
Morimoto, D., Walinda, E., Fukada, H., Sou, Yu-S, Kageyama, S., Hoshino, M., Fujii, T., Tsuchiya, H., Saeki, Y., Arita, K., Ariyoshi, M., Tochio, H., Iwai, K., Namba, K., Komatsu, M., Tanaka, K., & Shirakawa, M. (2015). The unexpected role of polyubiquitin chains in the formation of fibrillar aggregates. Nature communications, 6, 6116.

Auteurs

Julius T Dongdem (JT)

School of Life Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham, UK.
Department of Biochemistry and Molecular Medicine, School of Medicine, University for Development Studies, Tamale, Ghana.

Simon P Dawson (SP)

School of Life Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham, UK.

Robert Layfield (R)

School of Life Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH